Genprex
modulates the immune system | Genprex
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
19 of 44
Related slides by other companies
Cytek
Investor Day
June 2022
immune system is known to be incredibly complex but you would never suspect that if you look at the immune cells under the microscope | Cytek
Alkermes
Investor Day
March 2021
immune modulation in oncology based on engineered have pleiotropic effects and can act on every phase of the cancer immunity cycle alkermes is focusing on based therapies designed to increase visibility of tumor cells to immune system increase tumor killing potential of and cells mutation fusion remove suppressive signals in the tumor modern based drugs need a high degree of engineering to reduce side effects improve enhance efficacy natural killer journal of cancer cycle | Alkermes
Arbutus Biopharma
Investor Presentation
August 2023
pronged approach to therapeutic success | Arbutus Biopharma
Arbutus Biopharma
Investor Presentation
January 2024
pronged approach to therapeutic success | Arbutus Biopharma
Other recent decks by Genprex
See all presentations (2 decks)
Investor Presentation
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io